The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...